[Treatment of tobacco dependence: a responsibility of psychiatry and addiction medicine].
The World Health Organisation (WHO) considers smoking to be the biggest avoidable health risk. The consumption of tobacco leads to health hazards and resulting diseases, the consequences of which are far more serious than those emanating from other addictive substances. Approximately 27% of the German adult population smoke regularly and the proportion of smokers addicted to tobacco or nicotine is estimated to be around 60%. Many of these smokers have undertaken numerous unsuccessful attempts at abstinence. A professional support for smokers who are motivated to give up smoking enhances the chances of success. The current treatment guidelines recommend a combination of psychotherapeutic techniques (e.g. motivational interviewing, behavioural therapy-oriented support either individually or in groups) together with pharmacological support (e.g. nicotine replacement therapy, bupropion or varenicline). Certain subgroups (e.g. pregnant smokers, juvenile smokers and, in particular, smokers with a psychiatric co-morbidity) require a more intense psychotherapy and when necessary pharmacotherapeutic support.
Batra
A
A
Sektion Suchtforschung und Suchtmedizin, Universitätsklinik für Psychiatrie und Psychotherapie, Osianderstrasse 24, 72076, Tübingen, Deutschland. anil.batra@med.uni-tuebingen.de
Friederich
H M
HM
Lutz
U
U
D003131:Combined Modality Therapy; D005858:Germany / Q000453:epidemiology; D006801:Humans; D009538:Nicotine / Q000627:therapeutic use*; D011570:Psychiatry / Q000639:trends; D011613:Psychotherapy / Q000639:trends*; D012907:Smoking / Q000453:epidemiology / Q000523:psychology*; D016540:Smoking Cessation / Q000379:methods* / Q000523:psychology*; D000074606:Smoking Prevention; D014029:Tobacco Use Disorder / Q000453:epidemiology / Q000517:prevention & control* / Q000523:psychology*
D009538:Nicotine
Tob Control. 2006 Dec;15(6):464-71
17130376
Z Arztl Fortbild Qualitatssich. 2002 Jun;96(5):281-6
12168547
Nicotine Tob Res. 2007 Mar;9(3):315-27
17365764
Cochrane Database Syst Rev. 2000;(2):CD001008
10796583
Addiction. 2004 Dec;99(12):1586-98
15585050
Gen Hosp Psychiatry. 2009 Mar-Apr;31(2):131-6
19269533
Addiction. 2009 May;104(5):859-61
19413797
Cochrane Database Syst Rev. 2004;(3):CD000146
15266423
Br J Addict. 1991 Sep;86(9):1119-27
1932883
J Subst Abuse Treat. 2008 Jul;35(1):41-52
17931825
Addiction. 2000 Jan;95 Suppl 1:S3-7
10723815
Tob Control. 2007 Feb;16(1):15-21
17297068
Pneumologie. 2008 May;62(5):255-72
18461537
Fortschr Neurol Psychiatr. 2000 Feb;68(2):80-92
10719661
Arch Intern Med. 2009 Feb 9;169(3):230-5; discussion 235-6
19204212
Am J Health Promot. 1997 Sep-Oct;12(1):38-48
10170434
Addiction. 2008 Jan;103(1):146-54
18028247
Gesundheitswesen. 2001 Jun;63(6):363-9
11467218